No, we're not joking. And here's how it happened...

Back in 1978 Revlon purchased a company called Armour Pharmaceuticals for some $90 Million, the company had offices amongst other places in Eastbourne, UK. Revlon's new subsidiary company under it's blanket name, Revlon Healthcare, produced a treatment for Haemophilia, commonly known as "Factor VIII".

There was just one problem...

As it turns out, these products were made in a very dangerous way, they were actually described by Prof. Judith Graham Poole as "unethical" before they went into manufacture. Mrs Poole being the person who years earlier pioneered a safer alternative known as Cryoprecipitate or Cryo.

Despite a multitude of warnings that are well documented through the 1980's, the company pressed on with it's manufacture and distribution of the products. Products that as it came to light were infecting it's users with HIV and Hepatitis C. Even after Revlon's new found cash-cow suspected they may be transmitting the AIDS virus to people, they continued off-loading the product and the dollars kept rolling in.

By 1985 people who had been infected through these products began to be told.

In that same year, Revlon sold it's drug operation for $690 million in cash to the Rorer Group, now Rhône-Poulenc

In total some 1,243 people in the UK were infected with HIV through Factor concentrate products from various manufacturers and as of 2017 less than 250 are still alive.

Revlon has taken no responsibility for it's part in the scandal.


Facebook Conversations